In addition, the Kaplan–Meier survival analysis using the TCGA database revealed that breast cancer patients expressing high levels of E2F1 exhibit a poor prognosis, which is in harmony with ESRP1 (Supplementary Fig. S2F). This evidence concerns the gene E2F1 and breast cancer.